| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTHI | Common Stock | Award | $0 | +50K | +14.7% | $0.00 | 390K | Mar 26, 2025 | Direct | F1 |
| transaction | NTHI | Common Stock | Other | $0 | -5.99K | -1.81% | $0.00 | 325K | Mar 26, 2025 | By HCWG LLC | F2, F3, F4 |
| transaction | NTHI | Common Stock | Exercise of in-the-money or at-the-money derivative security | $1.41M | +117K | +36.09% | $12.00 | 442K | Mar 26, 2025 | By HCWG LLC | F5 |
| transaction | NTHI | Common Stock | Sale | -$1.41M | -56.3K | -12.73% | $25.00 | 386K | Mar 26, 2025 | By HCWG LLC | |
| transaction | NTHI | Common Stock | Sale | -$27.7K | -1.45K | -0.37% | $19.13 | 384K | Mar 26, 2025 | By HCWG LLC | |
| holding | NTHI | Common Stock | 29.3K | Mar 26, 2025 | By Orion Biomed Inc. | F6 | |||||
| holding | NTHI | Common Stock | 888K | Mar 26, 2025 | By NeuCen Biomedical Co. Ltd. | F7 | |||||
| holding | NTHI | Common Stock | 488K | Mar 26, 2025 | See footnote 8. | F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTHI | Warrant (right to buy) | Exercise of in-the-money or at-the-money derivative security | $0 | -117K | -100% | $0.00 | 0 | Mar 26, 2025 | Common Stock | 117K | $12.00 | By HCWG LLC | F9 |
| Id | Content |
|---|---|
| F1 | Grant of 50,000 shares of restricted common stock (the "Shares") pursuant to Issuer's 2023 Equity Incentive Plan. The Shares vest 100% seven months after the effective date of Issuer's initial listing. |
| F2 | Transfer of shares of common stock held by HCWG LLC ("HCWG") pursuant to agreement. The shares reported herein represent only Reporting Person's percentage interest in HCWG LLC. See also footnote 4. |
| F3 | Not applicable. Number of shares transferred was based on a per share value of $18. |
| F4 | Such shares are held by virtue of beneficial ownership of HCWG. The shares represent only Reporting Person's 37.5% interest in HCWG. |
| F5 | On 3/26/2025, in conjunction with Issuer's initial listing on Nasdaq, HCWG exercised a warrant to purchase 312,500 shares of Issuer's common stock at $12 per share. HCWG paid the exercise price on a cashless basis, resulting in Issuer's withholding 150,000 of the warrant shares to pay the exercise price and issuing to HCWG the remaining 162,500 shares of common stock. Number of shares reported herein as acquired and disposed of by the Reporting Person represents Reporting Person's indirect interest in HCWG. |
| F6 | Shares held by Orion Biotech Inc. ("Orion"). Orion is owned in part by Reporting Person, who disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. |
| F7 | Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. |
| F8 | Shares held by certain members of Reporting Person's family. Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein. |
| F9 | Not applicable. |